Listed

Stepan Co: Form 10-Q for the period ended Sep 30, 2013

Filed with the SEC on Oct 30, 2013 and accepted by EDGAR at Oct 30, 2013, 11:16 ET.

Share

Management's discussion and analysis

As filed, 69,111 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

The following is management’s discussion and analysis (MD&A) of certain significant factors that have affected the Company’s financial condition and results of operations during the interim period included in the accompanying condensed consolidated financial statements.

The matters discussed in the following discussion and analysis include forward-looking statements that are subject to certain risks, uncertainties and assumptions. Such forward-looking statements are intended to be identified in this document by the words, “anticipate,” “believe,” “estimate,” “expect,” “intend,” “may,” “objective,” “outlook,” “plan,” “project,” “possible,” “potential,” “should” and similar expressions. Actual results may vary materially.

Forward-looking statements speak only as of the date they are made, and the Company does not undertake any obligation to update them to reflect changes that occur after that date. Factors that could cause actual results to differ materially include the items described in Item 1A of the Company’s Annual Report on Form 10-K for the year ended December 31, 2012.

Overview

The Company produces and sells intermediate chemicals that are used in a wide variety of applications worldwide. The overall business comprises three reportable segments:

  • Surfactants – Surfactants, which accounted for 71 percent of consolidated net sales in the first nine months of 2013, are principal ingredients in consumer and industrial cleaning products such as detergents for washing clothes, dishes, carpets, floors and walls, as well as shampoos, body washes, toothpastes and fabric softeners. Other applications include germicidal quaternary compounds, lubricating ingredients, emulsifiers (for spreading agricultural products), plastics and composites and biodiesel. Surfactants are manufactured at six North American sites (five in the U.S. and one in Canada), three European sites (United Kingdom, France and Germany), three Latin American sites (Mexico, Brazil and Colombia) and two Asian sites (Philippines and Singapore). The Company also holds a 50 percent ownership interest in a joint venture, TIORCO, LLC (TIORCO), that markets chemical solutions for increasing the production of crude oil and natural gas from existing fields (enhanced oil recovery or EOR). The joint venture is accounted for under the equity method, and its financial results are excluded from surfactant segment operating results. Profits on sales of the Company’s surfactants to enhanced oil recovery customers are included in surfactants segment results.
  • Polymers – Polymers, which accounted for 25 percent of consolidated net sales in the first nine months of 2013, include two primary product lines: polyols and phthalic anhydride. Polyols are used in the manufacture of rigid laminate insulation board and panels for thermal insulation in the construction industry and are also a base raw material for flexible foams and coatings, adhesives, sealants and elastomers (collectively CASE products). Phthalic anhydride is used in unsaturated polyester resins, alkyd resins and plasticizers for applications in construction materials and components of automotive, boating and other consumer products. In addition, the Company uses phthalic anhydride internally in the production of polyols. In the U.S., polymer product lines are manufactured at the Company’s Millsdale, Illinois, site and beginning June 1, 2013, at the Company’s Columbus, Georgia, site (see the ‘Acquisition’ section for information regarding the Company’s June 1, 2013, acquisition). In Europe, polyols are manufactured at the Company’s subsidiaries in Germany and Poland. In Asia, polyols are currently toll produced for the Company’s 80-percent owned joint venture in Nanjing, China (see the ‘Segment Results’ section of this MD&A for a discussion regarding the Company’s requirement to move its China facility).
  • Specialty Products – Specialty products, which accounted for four percent of consolidated net sales in the first nine months of 2013, include flavors, emulsifiers and solubilizers used in the food, nutritional supplement and pharmaceutical industries. Specialty products are primarily manufactured at the Company’s Maywood, New Jersey, site and, in some instances, at outside contractors.

Acquisition

On June 1, 2013, the Company announced it had acquired the North American polyester resins business of Bayer MaterialScience LLC (BMS). Prior to the acquisition, BMS was a leading North American producer of powder polyester resins for metal coating applications and liquid polyester resins for CASE applications. The acquisition included a 21,000-ton production facility in Columbus, Georgia, and a modern research and development laboratory for customer technical support and new product development. Infrastructure is in place to allow for future expansion. Prior to the purchase, the acquired business had annual sales of approximately $64 million. As of the acquisition date, the new business became a part of the North American operations reporting unit included in the Company’s polymers reportable segment.

The acquisition has diversified the Company’s polyol product offering and is expected to accelerate Company growth in CASE and PUSH (polyurethane systems house) applications. The Company intends to make future capital expenditures to expand production capabilities at the site.

The total acquisition purchase price was $68,212,000 cash, of which $61,067,000 was paid at closing with $7,145,000 primarily for inventory paid over a three-month period (June 2013 through August 2013) pursuant to a transition services agreement with BMS. The acquisition was originally funded through the Company’s committed revolving credit agreement. Subsequent to closing on the acquisition, the Company completed a $100.0 million private placement loan, which was used in part to finance the acquisition (see the Liquidity and Capital Resources section of this MD&A for further information regarding the private placement borrowing).

The effect of the new business was immaterial to the Company’s earnings for the three and nine month periods ended September 30, 2013. The Company believes that the acquisition will be slightly accretive to 2013 earnings. See Note 2 of the condensed consolidated financial statements for further details regarding the acquisition.

Deferred Compensation Plans

The accounting for the Company’s deferred compensation plans can cause period-to-period fluctuations in Company expenses and profits. Compensation expense results when the values of Company common stock and mutual fund investment assets held for the plans increase, and compensation income results when the values of Company common stock and mutual fund investment assets decline. The pretax effect of all deferred compensation-related activities (including realized and unrealized gains and losses on the mutual fund assets held to fund the deferred compensation obligations) and the income statement line items in which the effects of the activities were recorded are displayed in the following table:

(In millions)

Income (Expense) For the Three Months Ended September 30 2013 2012 Change
Deferred Compensation (Administrative expense) $(2.2) $(1.3) $(0.9 )(1)
Realized/Unrealized Gains on Investments (Other, net) 1.1 0.7 0.4
Investment Income (Other, net) — — —
Pretax Income Effect $(1.1) $(0.6) $(0.5)
Income (Expense)
For the Nine Months Ended September 30
(In millions) 2013 2012 Change
Deferred Compensation (Administrative expense) $(3.5) $(6.3) $2.8 (1)
Realized/Unrealized Gains on Investments (Other, net) 2.1 1.7 0.4
Investment Income (Other, net) 0.1 — 0.1
Pretax Income Effect $(1.3) $(4.6) $3.3

(1) See the Corporate Expenses section of this management’s discussion and analysis for details regarding the quarter-over-quarter and year-over-year changes in deferred compensation expense.

Effects of Foreign Currency Translation

The Company’s foreign subsidiaries transact business and report financial results in their respective local currencies. As a result, foreign subsidiary income statements are translated into U.S. dollars at average foreign exchange rates appropriate for the reporting period. Because foreign exchange rates fluctuate against the U.S. dollar over time, foreign currency translation affects period-to-period comparisons of financial statement items (i.e., because foreign exchange rates fluctuate, similar period-to-period local currency results for a foreign subsidiary may translate into different U.S. dollar results). The following tables present the effects that foreign currency translation had on the period-over-period changes in consolidated net sales and various income line items for the three and nine month periods ended September 30, 2013 and 2012:

(In millions)

Three Months Ended September 30 2013 2012 Increase (Decrease) Increase Due to Foreign Translation
Net Sales $475.5 $441.0 $34.5 $0.9
Gross Profit 74.3 71.2 3.1 0.2
Operating Income 31.1 33.9 (2.8) 0.1
Pretax Income 27.8 30.2 (2.4) 0.2
Nine Months Ended September 30 Increase Increase Due to Foreign
(In millions) 2013 2012 (Decrease) Translation
Net Sales $1,406.5 $1,376.5 $30.0 $2.1
Gross Profit 220.7 221.4 (0.7) 0.1
Operating Income 95.2 104.1 (8.9) 0.1
Pretax Income 85.3 94.5 (9.2) 0.2

RESULTS OF OPERATIONS

Three Months Ended September 30, 2013 and 2012

Summary

Net income attributable to the Company for the third quarter of 2013 increased one percent quarter-over-quarter to $20.4 million, or $0.89 per diluted share, compared to $20.2 million, or $0.89 per diluted share, for the third quarter of 2012 (all per share data reflect the effects of the two-for-one common stock split that was effective December 14, 2012). Below is a summary discussion of the major factors leading to the quarter-over-quarter changes in net sales, profits and expenses. A detailed discussion of segment operating performance for the second quarter of 2013 follows the summary.

Consolidated net sales increased $34.5 million, or eight percent, quarter over quarter. A nine percent increase in sales volume and the favorable effects of foreign currency translation increased net sales by $41.4 million and $0.9 million, respectively. The surfactants and polymers segments accounted for most of the sales volume improvement, growing seven percent and 19 percent, respectively. A decline in average selling prices reduced the effect of increased sales volume and foreign currency translation by $7.8 million. Quarter-over-quarter declines in surfactant raw material costs drove the decline in average selling prices.

Operating income for the third quarter of 2013 declined $2.8 million, or eight percent, from operating income reported for the third quarter of 2012. Gross profit was up $3.1 million, or four percent, between quarters. Polymers segment gross profit improved, while the surfactants and specialty products segments posted lower profits. Polymers gross profit gain was largely driven by improvement for European operations and benefited from a $3.7 million insurance recovery. The decline in surfactants segment gross profit was principally attributable to North American operations where higher priced methyl ester inventories built up in prior periods to support the Singapore start-up combined with contractual selling price lags had a negative impact on margins. The North American decline was partially offset by positive contribution from the Singapore plant. Reduced margins for medium-chain triglyceride products used in food ingredient applications hurt the specialty products quarter-over-quarter results.

Operating expenses increased $5.9 million, or 16 percent, between quarters. The following summarizes the quarter-over-quarter changes in the individual income statement line items that comprise the Company’s operating expenses:

  • Selling expenses increased $0.7 million, or six percent, quarter over quarter. The only item of note was a $0.3 million increase related to the Company’s provisions for bad debts, which primarily related to general weakness in the European economy.
  • Administrative expenses increased $3.7 million, or 26 percent, quarter over quarter. Higher Asia operation expenses ($1.0 million) and increased expenses for deferred compensation ($0.9 million), corporate and other Company entity legal ($0.8 million) and salaries and the related fringe benefits ($0.7 million) accounted for the change in administrative expenses. The higher quarter-over-quarter expenses for Asia operations included a $0.7 million charge related to the Company’s China joint venture obligation to dismantle and remove the assets at its Nanjing, China, polymer plant. The increase in deferred compensation expense resulted from a greater increase in the value of Company common stock for the third quarter of 2013 than for the same quarter of 2012 (See the ‘Overview’ and ‘Corporate Expenses’ sections of this MD&A for further details). The rise in legal and salary-related expenses reflected additional spending to support the Company’s growth and innovation initiatives.
  • Research, development and technical service expenses were up $1.4 million, or 13 percent, quarter over quarter. Higher U.S. salary expenses and the related fringe benefits accounted for $0.6 million of the increase. Product registration under Europe’s REACH (Registration, Evaluation, Authorisation and Restriction of Chemicals) regulation and outside contract services accounted for $0.3 million and $0.2 million, of additional expenses, respectively.

Net interest expense for the third quarter of 2013 increased $0.3 million over net interest expense for the third quarter of 2012. The increase reflected higher average debt levels. On June 27, 2013, the Company borrowed $100.0 million pursuant to a private placement note purchase agreement that expires in 2025. The Company borrowed the funds primarily to finance the second quarter acquisition of the North American polyester resins business of BMS and expects to use the remaining proceeds for related capital expenditures and working capital as well as for general corporate purposes.

Other, net was $1.1 million of income for the third quarter of 2013 compared to $0.4 million of income for the same period of 2012. Net investment income (including realized and unrealized gains and losses) for the Company’s deferred compensation and supplemental defined contribution mutual fund assets was up $0.4 million quarter over quarter. Foreign exchange losses amounted to less than $0.1 million for the third quarter of 2013 compared to $0.3 million for the third quarter 2012.

The effective tax rate was 27.6 percent for the third quarter of 2013 compared to 32.8 percent for the third quarter of 2012. The decrease was primarily attributable to a greater percentage of consolidated income being generated outside the U.S. where the effective tax rates are lower. Also contributing to the effective tax rate decline was the federal research and development tax credit and the small agri-biodiesel producer tax credit which were extended retroactively from January 1, 2012 through December 31, 2013 when The American Taxpayer Relief Act of 2012 was signed into law on January 2, 2013. As a result of this legislation, the Company recorded a tax benefit of $0.5 million for amounts generated in the third quarter of 2013. For the first three quarters of 2013 the tax benefit related to the legislation was $2.6 million, of which $1.4 million related to 2012 (recorded in the first quarter of 2013).

Segment Results

(In thousands)

For the three months ended September 30, 2013 Surfactants Polymers Specialty Products Segment Results Corporate Total
Net sales $318,357 $137,649 $19,460 $475,466 — $475,466
Operating income 24,094 19,076 1,311 44,481 (13,396) 31,085
For the three months ended September 30, 2012
Net sales $313,076 $110,171 $17,731 $440,978 — $440,978
Operating income 25,948 14,981 3,763 44,692 (10,801) 33,891

Surfactants

Surfactants net sales for the third quarter of 2013 increased $5.3 million, or two percent, over net sales for the third quarter of 2012. A seven percent increase in sales volume drove the net sales improvement. All regions contributed to the higher sales volume, which favorably affected the quarter-over-quarter increase in net sales by $22.5 million. Lower average selling prices, precipitated by reduced raw material costs, and the unfavorable effects of foreign currency translation offset the impact of sales volume by $16.3 million and $0.9 million, respectively. A quarter-over-quarter comparison of net sales by region follows:

(In thousands)

For the Three Months Ended September 30, 2013 September 30, 2012 Increase (Decrease) Percent Change
North America $186,148 $190,949 $(4,801) -3
Europe 69,513 64,977 4,536 +7
Latin America 41,241 41,245 (4) —
Asia 21,455 15,905 5,550 +35
Total Surfactants Segment $318,357 $313,076 $5,281 +2

31

Net sales for North American operations declined three percent quarter over quarter. Sales volume increased one percent due to higher sales of laundry and cleaning products and increased demand from distributors, partially offset by weak demand for products used in oilfield and enhanced oil recovery applications. A four percent decrease in average selling prices, brought on by lower quarter-over-quarter raw material costs, more than offset the effect of increased sales volume. The decrease in average selling prices accounted for $7.0 million of the net sales decline. The increase in sales volume offset the impact of reduced selling prices by $2.7 million. The effects of foreign currency translation negatively affected the net sales change by $0.5 million.

Net sales for European operations increased seven percent between quarters due to a 12 percent increase in sales volume, which had a $7.7 million favorable effect. Much of the volume improvement resulted from increased sales of products used in consumer product applications (i.e., laundry and cleaning, personal care and household, institutional and industry products). Stronger demand from existing customers and new business accounted for the increase in consumer product sales. Also contributing to Europe’s sales volume gain was increased demand from most major distributors and agricultural chemical customers. A seven percent decline in average selling prices, which reflected a decrease in raw material costs, offset the impact of higher sales volume by $5.2 million. The favorable effects of foreign currency translation added $2.0 million to the quarter-over-quarter net sales increase.

Net sales for Latin American operations were unchanged quarter over quarter. A nine percent increase in sales volume was offset by a four percent drop in average selling prices and the unfavorable effects of foreign currency translation. Most of the sales volume improvement was generated by the Company’s Brazil subsidiary, which posted an 11 percent quarter-over-quarter volume increase, as the Company continued to grow its surfactants business in that country. The improved sales volume had a $3.7 million favorable impact on the quarter-over-quarter net sales change. The decline in average selling prices offset the effect of sales volume by $1.8 million. Lower raw material costs led to the selling price decrease. The effects of foreign currency translation reduced quarter-over-quarter net sales by $1.9 million. A weakening of the Brazilian real against the U.S. dollar caused the translation effect.

Net sales for Asia operations improved 35 percent due to a 38 percent increase in sales volume. The Company’s Singapore subsidiary accounted for the increase as that location was not commercially operational until the fourth quarter of 2012.

Surfactants operating income for the third quarter of 2013 declined $1.9 million, or seven percent, from operating income for the third quarter of 2012. Gross profit decreased $1.0 million due to a decline in profit for North American operations, which was partially offset by increased gross profit for Asia operations. Operating expenses increased $0.8 million, or four percent. Quarter-over-quarter comparisons of gross profit by region and total segment operating expenses and operating income follow:

(In thousands)

Gross Profit For the Three Months Ended September 30, 2013 September 30, 2012 Increase (Decrease) Percent Change
North America $29,364 $35,792 $(6,428) -18
Europe 5,149 4,592 557 +12
Latin America 5,325 5,233 92 +2
Asia 5,211 481 4,730 +NM
Total Surfactants Segment $45,049 $46,098 $(1,049) -2
Operating Expenses 20,955 20,150 805 +4
Operating Income $24,094 $25,948 $(1,854) -7

North American gross profit declined 18 percent quarter over quarter due to a decline in average unit margins precipitated by the consumption of high priced methyl ester inventories (built in prior periods to support the Singapore start-up), contractual selling price lags and increased competitive activity. An unfavorable mix of product sales (reduced sales of oilfield chemicals and increased sales of laundry and cleaning) also contributed to the decreased margin.

Gross profit for European operations improved 12 percent due to the previously noted 12 percent increase in sales volume.

Gross profit for Latin American operations increased two percent due to the nine percent increase in sales volume largely offset by a $0.4 million unfavorable effect of foreign currency translation.

Asia operations gross profit improvement was principally the result of the Singapore subsidiary’s contribution. The location was not commercially operational in the third quarter of 2012.

Operating expenses for the surfactants segment were up $0.8 million, or four percent, between quarters. Research and development and selling expenses accounted for $0.5 million and $0.2 million, respectively, of the increase. Higher salary and fringe benefit expenses for North American operations were a significant factor in both the increased research and development and selling expenses. Higher quarter-over-quarter expenditures for European product registration also contributed to the rise in research and development costs.

Polymers

Polymers net sales for the third quarter of 2013 increased $27.5 million, or 25 percent, over net sales for the same quarter of 2012. A 19 percent increase in sales volume, higher average selling prices and the favorable effects of foreign currency translation accounted for $21.0 million, $4.9 million and $1.6 million, respectively, of the net sales improvement. The current quarter benefited from the BMS North American polyester resins acquisition made in June, as the acquired business contributed $13.7 million and 40 percent of the changes in net sales and sales volume, respectively. A quarter-over-quarter comparison of net sales by region is displayed below:

(In thousands)

For the Three Months Ended September 30, 2013 September 30, 2012 Increase Percent Change
North America $84,096 $68,572 $15,524 +23
Europe 45,981 34,383 11,598 +34
Asia and Other 7,572 7,216 356 +5
Total Polymers Segment $137,649 $110,171 $27,478 +25

Net sales for North American operations increased 23 percent between quarters on sales volume that was up 17 percent. The increases in net sales and sales volume were largely attributable to the contribution of the BMS North American polyester resins acquisition made in June. The acquired business accounted for $13.7 million and 74 percent of the quarter-over-quarter changes in net sales and sales volume, respectively. Net sales for the Company’s pre-acquisition polymer business increased $1.8 million on sales volume that was essentially unchanged. Phthalic anhydride sales volume was up slightly but was offset by a small decrease in polyol sales volume.

Net sales for European operations increased 34 percent due to a 29 percent increase in sales volume and the effects of foreign currency translation, which accounted for $9.8 million and $1.4 million, respectively, of the net sales improvement. The increase in sales volume reflected the Company’s success in securing additional business at a number of major polyol customers, despite an uncertain European economy. Average selling prices increased one percent, which positively affected the quarter-over-quarter increase in net sales by $0.4 million.

Net sales for Asia and Other operations increased five percent quarter over quarter due to the effects of a favorable customer mix that more than offset a seven percent decline in sales volume. The decline in sales volume reflected a weaker economy in China and some lost business due to competitive activity.

As noted in prior filings, local government officials in Nanjing, China, have informed the Company that its manufacturing facility in that city will need to be relocated. The existing China plant is no longer producing. Customers’ requirements are being sourced from inventory produced in advance of the shutdown and from the Company’s U.S. and European plants and toll production in China, which negatively affects profit.

Polymer operating income for the third quarter of 2013 increased $4.1 million, or 27 percent, over operating income for the same quarter of 2012. Gross profit improved $6.1 million, largely due to improvement for European operations. The current quarter benefited from the receipt of a $3.7 million business interruption insurance recovery for lost business resulting from a 2011 fire that damaged polyol equipment at the Germany site. Operating expenses increased $2.0 million, or 36 percent. 2013 operating expenses included $0.7 million of estimated demolition costs for the China manufacturing plant. Quarter-over-quarter comparisons of gross profit by region and total segment operating expenses and operating income follow:

(In thousands)

Gross Profit For the Three Months Ended September 30, 2013 September 30, 2012 Increase (Decrease) Percent Change
North America $15,875 $15,547 $328 +2
Europe 10,411 3,988 6,423 +161
Asia and Other 274 932 (658) -71
Total Polymers Segment $26,560 $20,467 $6,093 +30
Operating Expenses 7,484 5,486 1,998 +36
Operating Income $19,076 $14,981 $4,095 +27

Gross profit for North American operations increased two percent quarter over quarter. Improved margins for polyols used in insulation applications and the acquired BMS business increased quarter-over-quarter gross profit. Gross profit for third quarter of 2012 greatly benefited from a large sale of a urethane systems product used in a new aircraft carrier. There were no such sales in 2013, which negatively impacted the quarter-over-change in gross profit.

The increase in gross profit for European operations was primarily driven by the previously mentioned $3.7 million insurance recovery and the 29 percent improvement in sales volume. Increased unit margins and the favorable effects of foreign currency also contributed.

The decline in gross profit for Asia and Other operations was due to reduced selling margins and the decline in sales volume. Outsourcing for the China location as opposed to manufacturing product led to the reduced margins.

Polymer operating expenses increased $2.0 million, or 36 percent, quarter over quarter. Included in the 2013 expenses was a $0.7 million charge for estimated dismantling costs for the manufacturing site in Nanjing, China. The majority of the remaining operating expense increase was attributable to higher selling ($0.6 million) and research and development ($0.5 million) expenses. Higher bad debt provisions, primarily for European customers, accounted for $0.3 million of the increased selling expenses. Higher salary and the related fringe benefit expenses were the major contributors to the increased research and development expenses.

Specialty Products

Net sales for the third quarter of 2013 increased $1.7 million, or 10 percent, over net sales for the third quarter of 2012. Operating income declined $2.5 million due to an unfavorable mix of sales and to higher raw material costs and manufacturing and operating expenses, especially for the Company’s medium-chain triglycerides that are used in food ingredient applications.

Corporate Expenses

Corporate expenses, which comprise operating expenses that are not allocated to the reportable segments, increased $2.6 million to $13.4 million for the third quarter of 2013 from $10.8 million for the third quarter of 2012. The quarter-over-quarter growth in corporate expenses was principally attributable to increased expenses for deferred compensation ($0.9 million), salaries and related fringe benefits ($0.7 million) and legal ($0.6 million).

Deferred compensation expenses increased to $2.2 million in the third quarter of 2013 from $1.3 million for the same quarter of last year. Most of the increase reflected a greater rise in Company common stock value in the third quarter of 2013 than in the third quarter of 2012 ($2.12 per share increase in 2013 compared to $0.97 per share increase in 2012). The following table presents the quarter-end Company common stock prices used in the computation of deferred compensation expense:

2013 September 30 June 30 2012 September 30 June 30
Company Stock Price $57.73 $55.61 $48.06 $47.09

The increase in salaries and fringe benefits reflected planned increases in personnel for 2013 and annual pay increases. In addition, expenses for the third quarter of 2012 included favorable adjustments to stock compensation (revised assessment regarding achievability of performance award targets) that did not recur in the third quarter of 2013. The increase in corporate legal expenses was largely due to additional spending to support the Company’s growth and innovation initiatives.

Nine Months Ended September 30, 2013 and 2012

Summary

Net income attributable to the Company for the first three quarters of 2013 declined three percent to $62.2 million, or $2.71 per diluted share, compared to $64.0 million, or $2.82 per diluted share, for the first three quarters of 2012 (all per share data reflect the effects of the two-for-one common stock split that was effective December 14, 2012). Below is a summary discussion of the major factors leading to the year-over-year changes in net sales, profits and expenses. A detailed discussion of segment operating performance for the first three quarters of 2013 follows the summary.

Consolidated net sales increased $30.0 million, or two percent, year over year due to a five percent improvement in sales volume and to the favorable effects of foreign currency translation, which accounted for $73.2 million and $2.1 million, respectively, of the net sales increase. Sales volumes for the surfactants and polymers segments improved six percent and five percent, respectively. Sales volume for the specialty products segment was down three percent. A decline in average selling prices had a $45.3 million unfavorable impact on the year-over-year net sales change. Decreased raw material costs for surfactants led to the drop in average selling prices.

Operating income for the first three quarters of 2013 declined $8.9 million, or nine percent, from operating income for the first three quarters of 2012. Gross profit decreased $0.7 million, or less than one percent. The polymers segment reported higher year-over-year gross profit, but the improvement was more than offset by gross profit declines for the surfactants and specialty products segments. Higher profits, largely due to greater sales volume, for European and North American operations led to the polymers result. In addition, 2013 European profits benefited from the receipt of a $3.7 million insurance recovery. Margin deterioration for the Company’s North American operations negatively impacted surfactants gross profit. Specialty products profits were negatively impacted by lower sales volumes and lower margins for medium-chain triglyceride products used in food ingredient applications.

Operating expenses increased $8.2 million, or seven percent, between years. The following summarizes the year-over-year changes in the individual income statement line items that comprise the Company’s operating expenses:

  • Selling expenses increased $2.3 million, or six percent, year over year. A number of small expense items led to the higher consolidated selling expenses, including increased bad debt expense ($0.6 million), European personnel costs ($0.4 million), Brazil sales office rent ($0.3 million) and product registration expenses for Singapore methyl esters ($0.2 million). In addition, the prior year included royalty income ($0.3 million) that did not recur in 2013. The year-over-year increase in bad debt expense was due to general weakness in the European economy and to favorable adjustments made for North American operations in 2012.
  • Administrative expenses increased $3.6 million, or eight percent, year over year. Expenses for Asia operations were up $1.6 million as the Company continued to invest in personnel and other resources to support Company growth initiatives in that region of the world. In addition, Asia operations administrative expenses included a $0.7 million charge for estimated dismantling costs for the manufacturing site in Nanjing, China. Other major contributors to the increase in consolidated administrative expenses included higher expenses for salaries and the related fringe benefits ($1.8 million), corporate and other Company entity legal ($1.8 million), hardware and software maintenance ($0.4 million) and U.S. expatriate support ($0.4 million).

The above increases were partially offset by a $2.8 million year-over-year decline in deferred compensation expense. The decline reflected a smaller year-over-year increase in the value of Company stock. See the ‘Overview’ and ‘Corporate Expenses’ sections of this MD&A for further details.

  • Research, development and technical service (R&D) expenses were up $2.3 million, or seven percent, year over year. Higher U.S. salary and related fringe benefit expenses ($0.9 million), European product registration expenses ($0.7 million) and expenses for outside contracted services ($0.4 million) were the largest contributors to the rise in R&D expenses. The higher salary and fringe benefit expenses reflected increased personnel to pursue the Company’s innovation opportunities.

The loss from the Company’s 50-percent equity joint venture (TIORCO) increased $0.2 million year over year primarily due to lower commission and technical service income.

Other, net of $1.6 million of income was essentially unchanged between years. Investment income (including realized and unrealized gains and losses) for the Company’s deferred compensation and supplemental defined contribution mutual fund assets was up $0.5 million. Foreign exchange losses increased $0.5 million to $0.7 million for the first three quarters of 2013 compared to $0.2 million for the same period of 2012.

The effective tax rate was 27.6 percent for the first three quarters of 2013 compared to 32.1 percent for the same period of 2012. The decrease was attributable to a greater percentage of consolidated income being generated outside the U.S. where the effective tax rates are lower. The decrease also reflected the federal research and development tax credit and the small agri-biodiesel producer tax credit which were extended retroactively from January 1, 2012 through December 31, 2013 when The American Taxpayer Relief Act of 2012 was signed into law on January 2, 2013. As a result of this legislation, the Company recorded a tax benefit of $1.4 million in the first quarter of 2013 for amounts generated in 2012 and a tax benefit of $1.2 million for amounts generated in 2013.

Segment Results

(In thousands)

For the nine months ended September 30, 2013 Surfactants Polymers Specialty Products Segment Results Corporate Total
Net sales $989,417 $354,972 $62,068 $1,406,457 — $1,406,457
Operating income 79,712 43,364 8,340 131,416 (36,168) 95,248
For the nine months ended September 30, 2012
Net sales $995,346 $320,843 $60,289 $1,376,478 — $1,376,478
Operating income 89,964 38,507 11,053 139,524 (35,412) 104,112

Surfactants

Surfactants net sales for the first three quarters of 2013 declined $5.9 million, or one percent, from net sales for the first three quarters of 2012. A six percent increase in sales volume favorably affected the year-over-year net sales change by $55.8 million. All regions reported sales volume improvements. A decrease in average selling prices and the unfavorable effects of foreign currency translation had negative effects of $60.3 million and $1.4 million, respectively, on the net sales change. Reduced raw material costs led to the average selling price decline. A year-over-year comparison of net sales by region follows:

(In thousands)

For the Nine Months Ended September 30, 2013 September 30, 2012 Increase (Decrease) Percent Change
North America $604,468 $625,864 $(21,396) -3
Europe 216,062 212,047 4,015 +2
Latin America 121,888 119,459 2,429 +2
Asia 46,999 37,976 9,023 +24
Total Surfactants Segment $989,417 $995,346 $(5,929) -1

38

Net sales for North American operations declined three percent year over year. Sales volume increased by two percent primarily due to higher sales of functional surfactants used in agricultural applications and biodiesel and to increased consumer product sales. Lower sales volumes of oil field chemicals partially offset the gains for agricultural chemicals and biodiesel. Average selling prices declined five percent, which had a $30.5 million negative effect on the year-over-year net sales change. Lower raw material costs and the effects of a customer contract selling price lag led to the decline in average selling prices. The increase in sales volume mitigated the impact of reduced selling prices by $10.0 million. The effects of foreign currency translation had a $0.9 million unfavorable effect on the net sales change.

Net sales for European operations increased two percent due to an eight percent increase in sales volume and to the favorable effects of foreign currency translation, which accounted for $16.9 million and $2.0 million, respectively, of the year-over-year growth in net sales. The sales volume increase reflected greater demand for Company products used in personal care, laundry and cleaning and agricultural chemical applications. The increased demand was principally from existing customers. Average selling prices declined six percent, which reduced the year-over-year net sales increase by $14.9 million. Lower raw material costs led to the reduction in selling prices.

Net sales for Latin American operations increased two percent as a result of a nine percent increase in sales volume partially offset by a four percent decline in average selling prices and the negative effects of foreign currency translation. The higher sales volume had an $11.2 million positive effect on the year-over-year net sales change, while the decline in selling prices and impact of foreign currency translation had negative effects of $5.8 million and $3.0 million, respectively. Sales volume for all three Latin American locations improved between years, with most of the increase derived from Brazil, as the Company continued to expand its surfactants franchise in that country. The decrease in average selling prices reflected declines in raw material costs.

Net sales for Asia operations increased 24 percent due to a 31 percent increase in sales volume. The sales volume increase reflected sales from the Singapore subsidiary, which was not commercially operational until the fourth quarter of 2012.

Surfactants operating income for the first three quarters of 2013 declined $10.3 million, or 11 percent, from operating income for the same period of 2012. Gross profit fell $6.8 million, or four percent, principally due to lower results from the segment’s North American operations. The effects of foreign currency translation contributed $0.6 million to the gross profit decline. Operating expenses increased $3.5 million, or six percent. Year-over-year comparisons of gross profit by region and total segment operating expenses and operating income follow:

(In thousands)

Gross Profit For the Nine Months Ended September 30, 2013 September 30, 2012 Increase (Decrease) Percent Change
North America $102,299 $116,707 $(14,408) -12
Europe 18,581 18,666 (85) —
Latin America 17,215 14,354 2,861 +20
Asia 6,932 2,074 4,858 +234
Total Surfactants Segment $145,027 $151,801 $(6,774) -4
Operating Expenses 65,315 61,837 3,478 +6
Operating Income $79,712 $89,964 $(10,252) -11

North American gross profit declined 12 percent year over year primarily due to the consumption of high priced methyl ester inventories, which were built up in prior periods to support the Singapore start-up, increased competitive activity and customer contract selling price lags, which unfavorably impacted selling margins in 2013 while favorably impacting margins in 2012. Approximately $2.2 million of reduced biodiesel gross profit was also a factor in the year-over-year decline in North American results.

Gross profit for European operations was essentially unchanged between years despite an eight percent increase in sales volume. A different mix of sales caused the decrease in gross profit, as most of the sales volume improvement came from the UK location where unit margins tend to be lower than product sold out of France.

Gross profit for Latin American operations increased 20 percent primarily due to the nine percent increase in sales volume. Average unit margins have also improved between years as a result of greater utilization of the Brazil site’s new manufacturing capacity.

Asia operations gross profit improvement was principally the result of the Singapore subsidiary’s contribution. The location was not commercially operational for the first three quarters of 2012.

Operating expenses for the surfactants segment were up $3.5 million, or six percent, year over year. Selling, administrative and research and development expenses were up $1.4 million, $1.2 million and $0.8 million, respectively. North American and Latin American operations accounted for $1.0 million and $0.4 million, respectively, of the selling expense increase. The accumulation of a number of small increases for Singapore methyl esters product registration costs, support costs for the TIORCO joint venture, travel expenses and bad debt provision contributed to the North American year-over-year change. In addition, 2012 included $0.3 million of royalty income that was nonrecurring. Latin American’s increase was attributable to rental expense for a sales office.

Asian and European operations contributed $0.8 and $0.4 million, respectively, to the increase in administrative expenses. The Asian increase reflected the accumulation of a number of items including salary, fringe benefit and software maintenance expenses. Higher salary and fringe benefit expenses accounted for most of the European increase.

The increase in research and development expenses comprised higher salary expense in North America and higher product registration expenses in Europe.

Polymers

Polymers net sales for the first three quarters of 2013 increased $34.1 million, or 11 percent, over net sales for the first three quarters of 2012. Higher average selling prices, a five percent increase in sales volume and the favorable effects of foreign currency translation accounted for $16.3 million, $14.7 million and $3.1 million, respectively, of the net sales improvement. The acquired BMS North American polyester resins business contributed $18.2 million to 2013 net sales. A year-over-year comparison of net sales by region is displayed below:

(In thousands)

For the Nine Months Ended September 30, 2013 September 30, 2012 Increase (Decrease) Percent Change
North America $218,689 $200,515 $18,174 +9
Europe 118,573 101,899 16,674 +16
Asia and Other 17,710 18,429 (719) -4
Total Polymers Segment $354,972 $320,843 $34,129 +11

Net sales for North American operations increased nine percent between years. The increase in net sales was largely attributable to the contribution of the BMS North American polyester resins acquisition made in June. The acquired business accounted for $18.2 million of the year-over-year change in net sales. Net sales for the Company’s pre-acquisition polymer business were unchanged between years on sales volume that declined four percent. Phthalic anhydride volume was down five percent due primarily to continued weak demand from polyester resin customers. Sales volume for rigid polyol products in insulation applications was down three percent largely as a result of a slow start to the construction season due to a protracted winter. Also affecting the year-over-year change in net sales was a significant 2012 sale of a urethane systems product used in a new aircraft carrier that did not recur in 2013. Average selling prices for the pre-acquisition business were up four percent year over year due to higher average raw material costs.

Net sales for European operations increased 16 percent due to a 12 percent improvement in sales volume, the effects of foreign currency translation and a one percent increase in average selling prices, which accounted for $12.4 million, $2.8 million and $1.5 million, respectively, of the growth in net sales. Additional business at a number of major polyol customers accounted for the sales volume increase. The strengthening of the Polish zloty against the U.S. dollar led to the foreign currency translation effect.

Net sales for Asia and Other operations declined four percent between years due to a nine percent decrease in sales volume. The sales decline reflected uncertainty in the China economy as well as some lost business due to competitive activity.

Polymer operating income for the first three quarters of 2013 increased $4.9 million, or 13 percent, over operating income for the first three quarters of 2012. Gross profit improved $7.8 million due to improvement for North American and European operations. 2013 profits benefited from the receipt of a $3.7 million insurance recovery related to lost business resulting from a 2011 fire that damaged polyol equipment at the Germany site. Operating expenses increased $2.9 million, or 18 percent. Year-over-year comparisons of gross profit by region and total segment operating expenses and operating income follow:

(In thousands)

Gross Profit For the Nine Months Ended September 30, 2013 September 30, 2012 Increase (Decrease) Percent Change
North America $42,256 $38,731 $3,525 +9
Europe 20,807 14,468 6,339 +44
Asia and Other (12) 2,056 (2,068) -101
Total Polymers Segment $63,051 $55,255 $7,796 +14
Operating Expenses 19,687 16,748 2,939 +18
Operating Income $43,364 $38,507 $4,857 +13

Gross profit for North American operations increased nine percent between years mainly due to lower costs and to the contribution derived from the BMS business acquisition. The year-over-year reduction in costs reflected elevated prior year costs associated with the Company’s triennial polymer plant maintenance shutdown. As a result of the shutdown, last year’s profit was adversely affected by $2.0 million of additional plant expenses and product outsourcing costs. In addition to the above, average unit margins improved between years due to a more favorable inventory position and to a more profitable mix of CASE and other specialty polyol sales. The year-over-year improvement in gross profit was tempered by a large third quarter 2012 sale of a urethane systems product used in a new aircraft carrier. There were no such sales in 2013.

The increase in gross profit for European operations was primarily driven by the previously mentioned $3.7 million insurance recovery and the 12 percent improvement in sales volume. Increased unit margins and the favorable effects of foreign currency also contributed.

The decline in gross profit for Asia and Other operations was due to the nine percent decrease in sales volume, reduced selling margins and higher expenses. As a result of ceasing manufacturing at the Nanjing site, products are now being outsourced from other Company locations or outside processors, which leads to reduced selling margins. In addition, during 2013 the Company accelerated $0.6 million of depreciation on all assets that were not projected to be moved to the new site.

Polymer operating expenses increased $2.9 million, or 18 percent, year over year. The operating expense increase resulted, in large part, from higher research and development ($0.9 million) and selling ($0.8 million) expenses and to the unfavorable effects of foreign currency translation. Higher North American operation expenses for salaries, fringe benefits, outside service and travel expenses were the major contributors to the increased research and development expenses. Europe and North America accounted for $0.5 million and $0.3 million, respectively, of the rise in selling expenses. In addition to the increased research and selling expenses, 2013 expenses included a $0.7 million charge for estimated dismantling costs for the manufacturing site in Nanjing, China.

Specialty Products

Net sales for the first three quarters of 2013 increased $1.8 million, or three percent, over net sales for the same period of 2012. Operating income declined $2.7 million due to higher raw material costs, competitive pricing pressures and increased manufacturing and operating expenses, especially for the Company’s medium-chain triglyceride products used in food ingredient applications.

Corporate Expenses

Corporate expenses increased $0.8 million to $36.2 million for the first three quarters of 2013 from $35.4 million for the first three quarters of 2012. In large part, the increase in corporate expenses reflected the Company’s continued investment in its growth and innovation initiatives. Increases in legal, salary and expatriate expenses accounted for $1.4 million, $0.8 million and $0.4 million, respectively of the year-over-year change in corporate expenses. In addition, statutory profit sharing expense in France was up $1.1 million, and corporate computer hardware and software expenses were up $0.4 million.

A $2.8 million decline in deferred compensation expense partially offset the foregoing increases. The value of Company common stock increased less in 2013 than in 2012, which drove the reduction in deferred compensation expense. The value of Company stock increased $2.19 per share for the first three quarters of 2013 compared to $7.98 per share for the same period of 2012. The following table presents the quarter-end Company common stock prices used in the computation of deferred compensation expense:

2013 September 30 2012 December 31 September 30 2011 December 31
Company Stock Price $57.73 $55.54 $48.06 $40.08

LIQUIDITY AND CAPITAL RESOURCES

For the nine months ended September 30, 2013, operating activities were a source of $81.7 million versus $78.0 million for the comparable period in 2012. For the current year period, investing cash outflows totaled $139.9 million and non-debt financing activities consumed $7.5 million. To fund these cash requirements, the Company increased debt by $93.8 million. Cash was increased by $26.2 million with exchange rates reducing cash by $1.9 million.

For the current year-to-date, net income was down by $2.4 million and working capital consumed $2.9 million more than for the comparable year-ago period. Cash outflows for investing activities were up by $76.7 million year over year. Cash provided by financing activities was a source of $86.3 million in 2013 compared to a use of $19.9 million in 2012.

For the current year-to-date, accounts receivable were a use of $41.1 million compared to a use of $5.5 million use for the comparable period in 2012. Inventories were a use of $9.6 million in 2013 versus a use of $44.1 million in 2012. Accounts payable and accrued liabilities were a source of $26.6 million in 2013 compared to a source of $24.7 million for the same period in 2012.

During the first nine months of both 2013 and 2012, changes in raw material costs had relatively little effect on working capital. The Company’s working capital investment is heavily influenced by the cost of crude oil and natural oils, from which many of its raw materials are derived. Fluctuations in raw material costs translate directly to inventory carrying costs and indirectly to customer selling prices and accounts receivable.

The higher current year accounts receivable cash use continued to be driven by current quarter 2013 net sales exceeding fourth quarter 2012 net sales more than for the comparable quarters last year. Accounts receivable turnover did not change significantly between December 31, 2012, and September 30, 2013 and turnover was not a significant factor in the year-over-year cash flow comparisons. The year-to-date inventory cash use was driven mainly by higher quantities to support customer service levels for the U.S. The Company has not changed its own payments practices related to its payables. It is management’s opinion that the Company’s liquidity is sufficient to provide for potential increases in working capital during the remainder of 2013.

Investing cash outflows for the current year-to-date included capital expenditures of $67.1 million compared to $60.9 million for the comparable period last year. Current period investing outflows also included $68.2 million for the acquisition of the North American polyester resins business of BMS, discussed previously. Other investing activities consumed $4.6 million in 2013 versus $2.3 million in 2012.

For 2013, the Company estimates that capital expenditures will range from $90 million to $100 million including capacity expansions in Brazil, Germany, Singapore and the United States.

The Company purchases its common shares in the open market from time to time to fund its own benefit plans and also to mitigate the dilutive effect of new shares issued under its benefit plans. The Company may also make open market repurchases as cash flows permit when, in management’s opinion, the Company’s shares are undervalued in the market. For the first nine months of 2013, the Company purchased 41,688 shares in the open market at a total cost of $2.3 million. At September 30, 2013, there were 958,312 shares remaining under the current share repurchase authorization. Also, as announced on June 12, 2013, the Company redeemed all shares of its 5 1⁄2 percent convertible preferred stock without par value (preferred stock) outstanding at August 9, 2013. Preferred stockholders tendered 835 shares of Company preferred stock for a redemption price of $25.00 per share plus accrued and unpaid dividends of $0.26354 per share. There are no longer any issued and outstanding shares of preferred stock.

As of September 30, 2013, the Company’s cash and cash equivalents totaled $103.1 million, including $34.8 million in two separate U.S. money market funds, each of which was rated AAA by Standard and Poor’s and Aaa by Moody’s. Cash in U.S. demand deposit accounts totaled $16.2 million and cash of the Company’s non-U.S. subsidiaries held outside the U.S. totaled $52.1 million at September 30, 2013.

Consolidated balance sheet debt increased by $94.4 million for the current year to date, from $182.4 million to $276.8 million. Since last year end, domestic debt increased by $95.7 million and foreign debt decreased by $1.3 million. Net debt (which is defined as total debt minus cash) increased by $68.2 million for the current year to date, from $105.5 million to $173.7 million. As of September 30, 2013, the ratio of total debt to total debt plus shareholders’ equity was 34.2 percent compared to 27.5 percent at December 31, 2012. As of September 30, 2013, the ratio of net debt to net debt plus shareholders’ equity was 24.6 percent compared to 18.0 percent at December 31, 2012.

At September 30, 2013, the Company’s debt included $247.9 million of unsecured private placement loans with maturities extending from 2013 through 2025. These loans are the Company’s primary source of long-term debt financing and are supplemented by bank credit facilities to meet short and medium-term needs.

On June 27, 2013, the Company entered into a $100.0 million long-term private placement loan with five insurance companies. This loan bears interest at a fixed rate of 3.86% with interest to be paid semi-annually and with equal annual principal payments beginning on June 27, 2019, and continuing through final maturity on June 27, 2025. Stepan used the net proceeds from the issuance of the notes primarily to finance the Company’s acquisition of the North American Polyester Resins business of BMS, including the production facility located in Columbus, Georgia, and expects to use the remaining proceeds for related capital expenditures and working capital as well as for general corporate purposes. This loan agreement requires the maintenance of certain financial ratios and covenants that are substantially identical to the Company’s existing long-term debt and customary events of default.

The Company has a committed $125.0 million multi-currency syndicated revolving credit agreement. The credit agreement allows the Company to make unsecured borrowings, as requested from time to time, for working capital and other corporate purposes. This unsecured facility is the Company’s primary source of short-term borrowings and is committed through September 20, 2017, with terms and conditions that are substantially equivalent to those of the Company’s other U.S. loan agreements. As of September 30, 2013, the Company had outstanding letters of credit of $2.8 million and no borrowings under this agreement, with $122.2 million remaining available. The Company anticipates that cash from operations, committed credit facilities and cash on hand will be sufficient to fund anticipated capital expenditures, working capital, dividends and other planned financial commitments for the foreseeable future.

Certain foreign subsidiaries of the Company maintain term loans and short-term bank lines of credit in their respective local currencies to meet working capital requirements as well as to fund capital expenditure programs and acquisitions. At September 30, 2013, the Company’s European subsidiaries had bank term loans of $6.4 million with maturities through 2016 and short-term bank debt of $20.8 million with remaining short-term borrowing capacity of $15.1 million. The Company’s Latin American subsidiaries had no short-term bank debt with $9.9 million of unused short-term borrowing capacity. The Company’s Philippine subsidiary had $1.7 million of short-term bank loans, which were guaranteed by the Company, with $6.3 million of unused borrowing capacity. The Company’s majority-owned joint venture in China had no short-term bank debt, with unused borrowing capacity of $6.5 million, on bank credit lines guaranteed by the Company.

The Company has material debt agreements that require the maintenance of minimum interest coverage and minimum net worth. These agreements also limit the incurrence of additional debt as well as the payment of dividends and repurchase of treasury shares. Testing for these agreements is based on the combined financial statements of the U.S. operations of the Company, Stepan Canada Inc., Stepan Specialty Products, LLC, Stepan Specialty Products B.V. and Stepan Asia Pte. Ltd. (the “Restricted Group”). Under the most restrictive of these debt covenants:

1. The Restricted Group must maintain a minimum interest coverage ratio, as defined within the agreements, of 2.0 to 1.0, for the preceding four calendar quarters.

2. The Restricted Group must maintain net worth of at least $275.0 million.

3. The Restricted Group must maintain a ratio of long-term debt to total capitalization, as defined in the agreements, not to exceed 55 percent.

4. The Restricted Group may pay dividends and purchase treasury shares after December 31, 2011, in amounts of up to $100.0 million plus 100 percent of net income and cash proceeds of stock option exercises, measured cumulatively after June 30, 2012. The maximum amount of dividends that could have been paid within this limitation is disclosed as unrestricted retained earnings in Note 13, Debt, in the Notes to Consolidated Financial Statements.

The Company believes it was in compliance with all of its loan agreements as of September 30, 2013. Based on current projections, the Company believes it will be in compliance with its loan agreements throughout 2013.

ENVIRONMENTAL AND LEGAL MATTERS

The Company is subject to extensive federal, state and local environmental laws and regulations. Although the Company’s environmental policies and practices are designed to ensure compliance with these laws and regulations, future developments and increasingly stringent environmental regulation could require the Company to make additional unforeseen environmental expenditures. The Company will continue to invest in the equipment and facilities necessary to comply with existing and future regulations. During the first nine months of 2013 and 2012, the Company’s expenditures for capital projects related to the environment were $3.4 million and $2.8 million, respectively. These projects are capitalized and depreciated over their estimated useful lives, which are typically 10 years. Recurring costs associated with the operation and maintenance of facilities for waste treatment and disposal and managing environmental compliance in ongoing operations at the Company’s manufacturing locations were $13.8 million and $13.7 million for the nine months ended September 30, 2013 and 2012, respectively. While difficult to project, it is not anticipated that these recurring expenses will increase significantly in the future.

Over the years, the Company has received requests for information related to or has been named by the government as a potentially responsible party at a number of waste disposal sites where cleanup costs have been or may be incurred under CERCLA and similar state statutes. In addition, damages are being claimed against the Company in general liability actions for alleged personal injury or property damage in the case of some disposal and plant sites. The Company believes that it has made adequate provisions for the costs it may incur with respect to the sites. It is the Company’s accounting policy to record liabilities when environmental assessments and/or remedial efforts are probable and the cost or range of possible costs can be reasonably estimated. When no amount within the range is a better estimate than any other amount, the minimum is accrued. Some of the factors on which the Company bases its estimates include information provided by feasibility studies, potentially responsible party negotiations and the development of remedial action plans. After partial remediation payments at certain sites, the Company has estimated a range of possible environmental and legal losses of $9.8 million to $29.0 million at September 30, 2013, compared to $10.3 million to $28.9 million at December 31, 2012. At September 30, 2013, and December 31, 2012, the Company’s accrued liability for such losses, which represented the Company’s best estimate within the estimated range of possible environmental and legal losses, was $14.8 million and $15.4 million, respectively. During the nine months of 2013, cash outlays related to legal and environmental matters approximated $1.8 million compared to $2.2 million for the same period in 2012.

For certain sites, the Company has responded to information requests made by federal, state or local government agencies but has received no response confirming or denying the Company’s stated positions. As such, estimates of the total costs, or range of possible costs, of remediation, if any, or the Company’s share of such costs, if any, cannot be determined with respect to these sites. Consequently, the Company is unable to predict the effect thereof on the Company’s financial position, cash flows and results of operations. Given the information available, management believes the Company has no liability at these sites. However, in the event of one or more adverse determinations with respect to such sites in any annual or interim period, the effect on the Company’s cash flows and results of operations for those periods could be material. Based upon the Company’s present knowledge with respect to its involvement at these sites, the possibility of other viable entities’ responsibilities for cleanup, and the extended period over which any costs would be incurred, the Company believes that these matters, individually and in the aggregate, will not have a material effect on the Company’s financial position. Certain of these matters are discussed in Item 1, Part 2, Legal Proceedings, in this report and in other filings of the Company with the Securities and Exchange Commission, which are available upon request from the Company. See also Note 8 to the condensed consolidated financial statements for a summary of the environmental proceedings related to certain environmental sites.

OUTLOOK

The Company delivered slightly improved results in the third quarter, and management remains optimistic about the Company’s long-term growth. The slow start to the year has made achieving full year earnings growth difficult, but the Company continues to pursue investments that should accelerate its growth. In 2014 the Company should realize the benefits of its recent acquisition and other capacity expansions. The Company’s balance sheet continues to be healthy, and dividends were increased for the forty-sixth consecutive year reflecting the Company’s continued commitment to generating shareholder value.

Global surfactant consumer product volumes should continue to grow, particularly in Brazil. The higher raw material cost inventory built to support the Singapore plant start-up and the subsequent decline in commodity prices negatively impacted year-to-date surfactant profit by $4.0 million. The positive side of this is that the Singapore methyl ester plant is operating well and is contributing to Company profitability, and the remaining negative impact of this inventory will not carry beyond 2013. Surfactants sold for use in enhanced oil recovery are expected to improve compared to the slow year-to-date results. Demand for agricultural surfactants should remain strong.

The polymer segment delivered strong quarterly results despite the continuing global economic uncertainty and the negative year-over-year impact of the Company’s China operations. The second quarter acquisition of the North America polyester resin business from BMS should be slightly accretive to earnings in 2013 and more so as capacity is increased to manufacture additional polyol products for CASE applications. Early fourth quarter polyol orders are strong in both North America and Europe, as it appears that the Company is getting some business not shipped earlier in the year due to poor weather.

CRITICAL ACCOUNTING POLICIES

There have been no changes to the critical accounting policies disclosed in the Company’s 2012 Annual Report on Form 10-K.

Controls and procedures

As filed, 733 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

a. Evaluation of Disclosure Controls and Procedures

Based on their evaluation of our disclosure controls and procedures as of the end of the most recent fiscal quarter covered by this Form 10-Q, our Chief Executive Officer and our Chief Financial Officer have concluded that our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) promulgated under the Securities Exchange Act of 1934) were effective as of September 30, 2013.

b. Changes in Internal Control Over Financial Reporting

There were no changes in internal controls that occurred during our most recent fiscal quarter that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2013-09-30. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Revenue3 months2013-07-01 to 2013-09-30$475.5mus-gaap:SalesRevenueNet
Revenue9 months2013-01-01 to 2013-09-30$1.41bnus-gaap:SalesRevenueNet
Cost of revenue3 months2013-07-01 to 2013-09-30$401.1mus-gaap:CostOfGoodsAndServicesSold
Cost of revenue9 months2013-01-01 to 2013-09-30$1.19bnus-gaap:CostOfGoodsAndServicesSold
Gross profit3 months2013-07-01 to 2013-09-30$74.3mus-gaap:GrossProfit
Gross profit9 months2013-01-01 to 2013-09-30$220.7mus-gaap:GrossProfit
Operating income3 months2013-07-01 to 2013-09-30$31.1mus-gaap:OperatingIncomeLoss
Operating income9 months2013-01-01 to 2013-09-30$95.2mus-gaap:OperatingIncomeLoss
Interest expense3 months2013-07-01 to 2013-09-30$3.0mus-gaap:InterestExpense
Interest expense9 months2013-01-01 to 2013-09-30$7.5mus-gaap:InterestExpense
Income tax3 months2013-07-01 to 2013-09-30$7.7mus-gaap:IncomeTaxExpenseBenefit
Income tax9 months2013-01-01 to 2013-09-30$23.5mus-gaap:IncomeTaxExpenseBenefit
Net income3 months2013-07-01 to 2013-09-30$20.4mus-gaap:NetIncomeLoss
Net income9 months2013-01-01 to 2013-09-30$62.2mus-gaap:NetIncomeLoss
Diluted EPS3 months2013-07-01 to 2013-09-30$0.89us-gaap:EarningsPerShareDiluted
Diluted EPS9 months2013-01-01 to 2013-09-30$2.71us-gaap:EarningsPerShareDiluted
Basic EPS3 months2013-07-01 to 2013-09-30$0.90us-gaap:EarningsPerShareBasic
Basic EPS9 months2013-01-01 to 2013-09-30$2.75us-gaap:EarningsPerShareBasic
Diluted shares (weighted)3 months2013-07-01 to 2013-09-3022,936,000 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Diluted shares (weighted)9 months2013-01-01 to 2013-09-3022,914,000 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Operating cash flow9 months2013-01-01 to 2013-09-30$81.7mus-gaap:NetCashProvidedByUsedInOperatingActivities
Capital expenditure9 months2013-01-01 to 2013-09-30$67.1mus-gaap:PaymentsToAcquirePropertyPlantAndEquipment
Dividends paid9 months2013-01-01 to 2013-09-30$10.7mus-gaap:PaymentsOfDividends
Share repurchases9 months2013-01-01 to 2013-09-30$2.3mus-gaap:PaymentsForRepurchaseOfCommonStock
Cash and equivalentsAt period end2013-09-30$103.1mus-gaap:CashAndCashEquivalentsAtCarryingValue
Current assetsAt period end2013-09-30$608.9mus-gaap:AssetsCurrent
Total assetsAt period end2013-09-30$1.15bnus-gaap:Assets
Current liabilitiesAt period end2013-09-30$265.9mus-gaap:LiabilitiesCurrent
Long-term debtAt period end2013-09-30$241.6mus-gaap:LongTermDebtNoncurrent
Current portion of debtAt period end2013-09-30$35.2mus-gaap:LongTermDebtCurrent
Shareholders' equityAt period end2013-09-30$531.3mus-gaap:StockholdersEquity

Source: SEC EDGAR, the filing index for accession 0001193125-13-417585. Last ingested by Listed: Nov 10, 2026, 21:16 ET. Listed shows no prices and gives no investment advice.